30 June 2026Regulatory Update for Therapeutic Product Registration (30 June 2026)AudiencesIndustry memberProduct typeTherapeutic ProductsExtension of e-labelling to P and GSL medicinesRegulatory Updates
Extension of e-labelling to P and GSL medicines
Publisher
Singapore
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- HSA (Singapore)
- Region
- Singapore
- Scope
- Regulatory
- Published
- July 15, 2026
- Language
- EN
Topics
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Extension of e-labelling to P and GSL medicines
Source route
Continue on hsa.gov.sg
Leave the platform to read the original full article on the publisher site.
Source: HSA (Singapore)
Scope: Regulatory
Related coverage
More related coverage
Influenza vaccines marketed in the UK
Influenza vaccines marketed in the UK for 2026 to 2027, including ovalbumin content.
National mycobacterium reference service - South: user handbook
How to label, package and submit specimens to the laboratory for diagnostic testing.
Immunisation
Information for immunisation practitioners and other health professionals.
Bacteriology reference department user manual
A guide to UKHSA's bacteriology reference department (BRD), its units and the tests and services it...